Dr. Reddy's Laboratories Limited
RDY
$14.49
$0.140.98%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.37% | 6.56% | -0.29% | -0.68% | 1.48% |
| Total Depreciation and Amortization | 15.98% | 21.23% | 16.59% | 12.46% | 11.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 957.93% | -11.71% | 193.32% | 157.09% | 71.72% |
| Change in Net Operating Assets | 47.36% | 45.45% | 1.84% | -46.92% | -205.08% |
| Cash from Operations | 68.75% | 66.83% | 19.51% | -0.70% | -33.83% |
| Capital Expenditure | -1.41% | -20.45% | -59.90% | -64.04% | -80.08% |
| Sale of Property, Plant, and Equipment | -76.26% | -76.10% | -72.71% | -52.32% | -45.06% |
| Cash Acquisitions | 96.89% | 96.89% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -219.73% | -462.09% | 170.69% | 187.60% | 160.71% |
| Cash from Investing | 10.26% | 31.14% | -6.65% | -41.72% | -24.12% |
| Total Debt Issued | -77.31% | -101.18% | -12.86% | 163.53% | 233.68% |
| Total Debt Repaid | 15.38% | -269.74% | -189.47% | 73.84% | 85.17% |
| Issuance of Common Stock | 54.46% | 64.47% | -50.34% | -76.02% | -78.59% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 4.10% | 4.10% | 1.09% | 1.09% | 1.09% |
| Other Financing Activities | -208.04% | -197.76% | 229.76% | 257.68% | 289.00% |
| Cash from Financing | -123.68% | -142.06% | 16.54% | 597.54% | 434.86% |
| Foreign Exchange rate Adjustments | 1,309.01% | 543.88% | 698.99% | 454.01% | 10.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.14% | 40.79% | 281.55% | 430.31% | 308.11% |